Patient Prefer Adher
-
Patient Prefer Adher · Jan 2014
Willingness to pay for ovulation induction treatment in case of WHO II anovulation: a study using the contingent valuation method.
To measure the willingness to pay (WTP) of women aged 18-45 years to receive drug treatment for ovulation induction (ie, the social value of normal cycles of ovulation for a woman of childbearing age) in order to feed the debate about the funding of fertility cares. ⋯ Medical treatment for ovulation induction is highly socially desirable in Quebec.
-
Patient Prefer Adher · Jan 2014
Assessment of selected quality fields of nursing care in neurosurgical wards: a prospective study of 530 people - multicenter studies.
One of the elements influencing the assessment of nursing care quality is the assessment of the nurse's functions that determine the nurse's particular tasks. The aim of this work was to assess selected tasks involved in the nurse's caring function, which influence nursing care quality on neurosurgical wards, on the basis of patients' and nursing staff's opinions. ⋯ Selected tasks in the field of the caring function of nurses were assessed differently by particular groups. There were no statistically significant differences in the assessment of particular tasks in the opinions of patients and nurses, which means that both examined groups similarly assessed tasks involved in the nurse's caring function, which influence nursing care quality.
-
Patient Prefer Adher · Jan 2014
Enhanced patient support services improve patient persistence with multiple sclerosis treatment.
Subcutaneous interferon beta-1a (sc IFN β-1a) therapy (44 µg or 22 µg, three times weekly) improves relapse rates and disability progression in patients with relapsing multiple sclerosis (MS). While early treatment with disease-modifying drugs may maximize therapeutic benefit, patients with low adherence or long treatment gaps are at increased risk of relapse. MySupport is an industry-sponsored program that provides support to patients with MS who have been prescribed sc IFN β-1a in the UK or Republic of Ireland (ROI), via telephone and text messaging, website access, and (in some cases) face-to-face support from a dedicated MySupport Nurse. The aim of this audit was to assess if the MySupport program in the ROI could improve persistence to sc IFN β-1a therapy. ⋯ A personalized support program, utilizing one-to-one nursing support and additional support materials, can increase the probability of patients with MS remaining on disease-modifying drug treatment.
-
Patient Prefer Adher · Jan 2014
Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study.
To evaluate the appropriateness of laboratory-test monitoring recommended for patients on chronic medication therapies in the Lebanese community setting. ⋯ Seventy-three percent (73%) of the study group were receiving incomplete therapeutic/safety laboratory-test monitoring recommended for patients on chronic medication in the Lebanese community. It is concluded from the results that patients need to better understand the importance of recommended test monitoring for the safe and effective use of their medications. Education by physicians may be required to achieve better understanding.
-
Patient Prefer Adher · Jan 2013
Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis.
To assess the impact of reduced frequency of oral therapies from multiple-dosing schedules to a once-daily (OD) dosing schedule on adherence, compliance, persistence, and associated economic impact. ⋯ Current meta-analyses suggested that across acute and chronic disease states, reducing dosage frequency from multiple dosing to OD dosing may improve adherence to therapies among patients. Improving adherence may result in subsequent decreases in health care costs.